Did you mean 13967 2,3 4?
Displaying drugs 8726 - 8750 of 11007 in total
Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate
Experimental
Matched Name: … Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate …
Matched Iupac: … 5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}propanamido]propanamido]pentanedioic acid ... (2R)-2-[(2S)-2-[(2R)-2-{[(2R,3R,4R,5S,6R)-2-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin ... -1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3-acetamido- …
Matched Iupac: … 5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}propanamido]propanamido]pentanedioic acid ... (2R)-2-[(2S)-2-[(2R)-2-{[(2R,3R,4R,5S,6R)-2-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin ... -1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3-acetamido- …
Limaprost
Limaprost (as Limaprost alfadex; CAS number 88852-12-4) is an oral prostaglandin E1 analog. Prostaglandins act on a variety of cells such as vascular smooth muscle cells causing constriction or dilation, on platelets causing aggregation or disaggregation and on spinal neurons causing pain. Prostaglandins have a wide variety of actions, including,...
Investigational
Matched Iupac: … (2E)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S,5S)-3-hydroxy-5-methylnon-1-en-1-yl]-5-oxocyclopentyl]hept-2-enoic …
Matched Description: … Limaprost (as Limaprost alfadex; CAS number 88852-12-4) is an oral prostaglandin E1 analog. …
Matched Products: … OPALMON TABLETS 5 ug …
Matched Description: … Limaprost (as Limaprost alfadex; CAS number 88852-12-4) is an oral prostaglandin E1 analog. …
Matched Products: … OPALMON TABLETS 5 ug …
2-Tridecanoyloxy-Pentadecanoic Acid
Experimental
Matched Name: … 2-Tridecanoyloxy-Pentadecanoic Acid …
N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)
Experimental
Matched Name: … N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl) …
Matched Iupac: … methyl 2-{4'-[(N-{1-[(1H-imidazol-2-yl)methyl]piperidin-4-yl}-1-(4-pentylphenyl)formamido)methyl]-[1,1 ... '-biphenyl]-4-yl}acetate …
Matched Iupac: … methyl 2-{4'-[(N-{1-[(1H-imidazol-2-yl)methyl]piperidin-4-yl}-1-(4-pentylphenyl)formamido)methyl]-[1,1 ... '-biphenyl]-4-yl}acetate …
2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE
Experimental
Matched Name: … 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE …
Matched Iupac: … 6-(cyclohexylmethoxy)-N-phenyl-7H-purin-2-amine …
Matched Iupac: … 6-(cyclohexylmethoxy)-N-phenyl-7H-purin-2-amine …
Anti-GD2 monoclonal antibody 3F8
Anti-GD2 monoclonal antibody 3F8 is under investigation in clinical trial NCT00089258 (Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment).
Investigational
Xaluritamig
Xaluritamig is a novel humanized bispecific T cell recruiting antibody cross-reactive to human and nonhuman primate STEAP1 and CD3.
Investigational
Matched Synonyms: … STEAP1) (human-Mus musculus clone 2F3.013 N67Q γ1-chain) fusion protein with peptide linker (GGGGS)2 …
DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID
Experimental
Matched Name: … DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID …
Matched Iupac: … [(1E,5S)-5-amino-5-carboxypent-1-en-1-yl]trihydroxyboranuide …
Matched Iupac: … [(1E,5S)-5-amino-5-carboxypent-1-en-1-yl]trihydroxyboranuide …
2,6-anhydro-3-deoxy-3-fluoronononic acid
Experimental
Matched Synonyms: … 3-deoxy-3-fluoro-D-erythro-α-L-manno-non-2-ulopyranosonic acid …
Matched Iupac: … (2R,3R,4R,5R,6S)-3-fluoro-2,4,5-trihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid …
Matched Iupac: … (2R,3R,4R,5R,6S)-3-fluoro-2,4,5-trihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid …
GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE
Experimental
Matched Name: … GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE …
Matched Iupac: … {[(2R,3aR,4R,6R,6aR)-4-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-6-(hydroxymethyl)-tetrahydro-2H-furo ... [3,4-d][1,3]dioxol-2-yl]methyl}phosphonic acid …
Matched Iupac: … {[(2R,3aR,4R,6R,6aR)-4-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-6-(hydroxymethyl)-tetrahydro-2H-furo ... [3,4-d][1,3]dioxol-2-yl]methyl}phosphonic acid …
N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine
Experimental
INM004
INM004, a Neutralizing Equine Anti-Stx Hyperimmune Immunoglobulin F(Ab')2 Fragment, is currently being investigated to treat Shiga-toxin producing bacterial infection relating to the prevention of hemolytic uremic syndrome.
Investigational
Matched Synonyms: … Anti-Shiga toxin hyperimmune equine immunoglobulin F(ab')2 fragment ... Neutralizing equine anti-Stx hyperimmune immunoglobulin F(ab')2 fragment …
Matched Description: … INM004, a Neutralizing Equine Anti-Stx Hyperimmune Immunoglobulin F(Ab')2 Fragment, is currently being …
Matched Description: … INM004, a Neutralizing Equine Anti-Stx Hyperimmune Immunoglobulin F(Ab')2 Fragment, is currently being …
Binodenoson
Binodenoson is a pharmacologic stress agent specific to the only adenosine receptor necessary for increased cardiac blood flow, the A2A receptor. This specificity allows Binodenoson to deliver - in a single injection - a more effective dose of medication with fewer side effects than current treatments, which typically require a...
Investigational
Matched Synonyms: … 2-((Cyclohexylmethylene)hydrazino)adenosine …
Matched Iupac: … (2R,3R,4S,5R)-2-{6-amino-2-[(2E)-2-(cyclohexylmethylidene)hydrazin-1-yl]-9H-purin-9-yl}-5-(hydroxymethyl …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Iupac: … (2R,3R,4S,5R)-2-{6-amino-2-[(2E)-2-(cyclohexylmethylidene)hydrazin-1-yl]-9H-purin-9-yl}-5-(hydroxymethyl …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Immucin
Investigational
(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE
Experimental
Matched Name: … (3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE …
Matched Iupac: … (3S)-N-(3-bromophenyl)-1-cyclohexyl-5-oxopyrrolidine-3-carboxamide …
Matched Iupac: … (3S)-N-(3-bromophenyl)-1-cyclohexyl-5-oxopyrrolidine-3-carboxamide …
Cobnabexagene anvuparvovec
Experimental
1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol
Experimental
Matched Name: … 1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol …
Matched Iupac: … (2,3-dihydroxypropoxy)[(2R)-3-(hexadecanoyloxy)-2-({8-[(1S,2R)-2-hexylcyclopropyl]octanoyl}oxy)propoxy …
Matched Iupac: … (2,3-dihydroxypropoxy)[(2R)-3-(hexadecanoyloxy)-2-({8-[(1S,2R)-2-hexylcyclopropyl]octanoyl}oxy)propoxy …
2,3-diphenyl-1H-indole-7-carboxylic acid
Experimental
Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)
The Recombinant SARS-CoV-2 Vaccine was created by inserting genes of the SARS-CoV-2 spike protein’s receptor-binding domain into a baculovirus expression system[F4738, A226853]. In pre-clinical trial testing on mice, rabbits, and non-human primates, the candidate was able to induce a functional antibody response within 7-14 days of initial injection . It...
Investigational
Matched Name: … Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) …
Matched Description: … The Recombinant SARS-CoV-2 Vaccine was created by inserting genes of the SARS-CoV-2 spike protein’s receptor-binding ... It also provided protection in non-human primates to an in vivo challenge with SARS-CoV-2[A226853]. …
Matched Description: … The Recombinant SARS-CoV-2 Vaccine was created by inserting genes of the SARS-CoV-2 spike protein’s receptor-binding ... It also provided protection in non-human primates to an in vivo challenge with SARS-CoV-2[A226853]. …
BBV152
BBV152 is a vaccine candidate created by the Indian Council of Medical Research (ICMR). The candidate, a whole virion inactivated SARS-CoV-2 vaccine, was developed from a well-known SARS-CoV-2 strain and a vero cell platform (CCL-81) with adjuncts of either aluminum hydroxide gel (Algel) or a novel TLR7/8 agonist adsorbed gel....
Investigational
Matched Synonyms: … Whole-Virion Inactivated SARS-CoV-2 Vaccine …
Matched Description: … The candidate, a whole virion inactivated SARS-CoV-2 vaccine, was developed from a well-known SARS-CoV ... -2 strain and a vero cell platform (CCL-81) with adjuncts of either aluminum hydroxide gel (Algel) or ... Thus, as of July 2020, BBV152 is in Phase 1/2 clinical trials assessing safety and immunogenicity in …
Matched Description: … The candidate, a whole virion inactivated SARS-CoV-2 vaccine, was developed from a well-known SARS-CoV ... -2 strain and a vero cell platform (CCL-81) with adjuncts of either aluminum hydroxide gel (Algel) or ... Thus, as of July 2020, BBV152 is in Phase 1/2 clinical trials assessing safety and immunogenicity in …
Bemarituzumab
Bemarituzumab is under investigation in clinical trial NCT03694522 (A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (Mfolfox6) in Gastric/gastroesophageal Junction Cancer (FIGHT)).
Investigational
Vinpocetine
Vinpocetine has been investigated for the treatment of Epilepsy.
Investigational
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Products: … CAVINTON TABLET 5 mg …
Matched Products: … CAVINTON TABLET 5 mg …
1-Hydroxyamine-2-Isobutylmalonic Acid
Experimental
Matched Name: … 1-Hydroxyamine-2-Isobutylmalonic Acid …
Matched Iupac: … (2R)-2-(hydroxycarbamoyl)-4-methylpentanoic acid …
Matched Iupac: … (2R)-2-(hydroxycarbamoyl)-4-methylpentanoic acid …
S-(2-Acetamidoethyl) hexadecanethioate
Experimental
Matched Name: … S-(2-Acetamidoethyl) hexadecanethioate …
Matched Iupac: … N-[2-(hexadecanoylsulfanyl)ethyl]acetamide …
Matched Iupac: … N-[2-(hexadecanoylsulfanyl)ethyl]acetamide …
Displaying drugs 8726 - 8750 of 11007 in total